Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 5
2005 4
2006 6
2007 7
2008 4
2009 8
2010 5
2011 9
2012 11
2013 20
2014 12
2015 8
2016 11
2017 11
2018 9
2019 20
2020 11
2021 12
2022 7
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Impact of patient characteristic factors on the dynamics of liver glucose metabolism: Evaluation of multiparametric imaging with dynamic whole-body 18 F-fluorodeoxyglucose-positron emission tomography.
Tonda K, Iwabuchi Y, Shiga T, Owaki Y, Fujita A, Nakahara T, Sakurai R, Shimizu A, Yamada Y, Okada M, Jinzaki M. Tonda K, et al. Among authors: shiga t. Diabetes Obes Metab. 2023 Dec;25(12):3521-3528. doi: 10.1111/dom.15247. Epub 2023 Aug 17. Diabetes Obes Metab. 2023. PMID: 37589247
Impaired neuronal integrity in traumatic brain injury detected by 123I-iomazenil single photon emission computed tomography and MRI.
Kato H, Nakagawara J, Hachisuka K, Hatazawa J, Ikoma K, Suehiro E, Iida H, Ogasawara K, Iizuka O, Ishiai S, Ichikawa T, Nariai T, Okazaki T, Shiga T, Mori E. Kato H, et al. Among authors: shiga t. J Cereb Blood Flow Metab. 2022 Dec;42(12):2245-2254. doi: 10.1177/0271678X221113001. Epub 2022 Jul 7. J Cereb Blood Flow Metab. 2022. PMID: 35796498 Free PMC article.
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.
Inaki A, Shiga T, Tsushima Y, Jinguji M, Wakabayashi H, Kayano D, Akatani N, Yamase T, Kunita Y, Watanabe S, Hiromasa T, Mori H, Hirata K, Watanabe S, Higuchi T, Tomonaga H, Kinuya S. Inaki A, et al. Among authors: shiga t. Ann Nucl Med. 2022 Mar;36(3):267-278. doi: 10.1007/s12149-021-01699-0. Epub 2021 Dec 6. Ann Nucl Med. 2022. PMID: 34870794 Free PMC article. Clinical Trial.
161 results